These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4738907)

  • 1. [Cross antigenic reactivity of cow and sheep kappa caseinoglycopeptides with antigens of M and N blood group substances].
    Fiat AM; Goussault Y; Jollés P
    Immunochemistry; 1973 May; 10(5):355-7. PubMed ID: 4738907
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild acid (polystyrenesulfonic acid) and alkaline (triethylamine) hydrolysis of M and N blood group substances.
    Lisowska E; Romanowska E; Baranowski T
    Arch Immunol Ther Exp (Warsz); 1969; 17(3):300-5. PubMed ID: 5802829
    [No Abstract]   [Full Text] [Related]  

  • 3. The degradation of M and N blood group glycoproteins and glycopeptides with alkaline borohydride.
    Lisowska E
    Eur J Biochem; 1969 Oct; 10(3):574-9. PubMed ID: 5388499
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on phytohemagglutinins. 8. A phytohemagglutinin receptor from human erythrocytes.
    Kubánek J; Entlicher G; Kocourek J
    Biochim Biophys Acta; 1973 Mar; 304(1):93-102. PubMed ID: 4700001
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative haemagglutination. 5. Influence of in vivo ageing and neuraminidase treatment on the M and N antigens of human red cells.
    Greenwalt TJ; Steane EA
    Br J Haematol; 1973 Aug; 25(2):217-26. PubMed ID: 4737859
    [No Abstract]   [Full Text] [Related]  

  • 6. I-, MN- and Pr1/Pr2-activity of human erythrocyte glycoprotein fractions obtained by ficin treatment.
    Roelcke D; Ebert W; Metz J; Weicker H
    Vox Sang; 1971 Oct; 21(4):352-61. PubMed ID: 5000790
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural variability of the neutral carbohydrate moiety of cow colostrum kappa-casein as a function of time after parturition. Identification of a tetrasaccharide with blood group I specificity.
    Fiat AM; Chevan J; Jollès P; De Waard P; Vliegenthart JF; Piller F; Cartron JP
    Eur J Biochem; 1988 Apr; 173(2):253-9. PubMed ID: 3360006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed-field polyagglutinability due to tn: a further example.
    Moore BP; Marsh S; Laschinger C; Simpson S
    Transfusion; 1975; 15(1):54-7. PubMed ID: 1114514
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-N reagents in elucidation of the genetical basis of human blood-group MN specificities.
    Springer GF; Tegtmeyer H; Huprikar SV
    Vox Sang; 1972; 22(4):325-43. PubMed ID: 4111981
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and properties of human blood-group NN and meconium-Vg antigens.
    Springer GF; Nagai Y; Tegtmeyer H
    Biochemistry; 1966 Oct; 5(10):3254-72. PubMed ID: 4961656
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigations on cellular blood-group substances. I. Isolation and chemical composition of blood-group ABH and Le-b isoantigens of sphingoglycolipid nature.
    Hakomori S; Strycharz GD
    Biochemistry; 1968 Apr; 7(4):1279-86. PubMed ID: 5677817
    [No Abstract]   [Full Text] [Related]  

  • 12. The sugar part of kappa-caseins from cow milk and colostrum and its microheterogeneity.
    Fournet B; Fiat AM; Montreuil J; Jollès P
    Biochimie; 1975; 57(2):161-5. PubMed ID: 1138973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrates of the glycopeptides released by the action of rennin on whole milk.
    Sinkinson G; Wheelock JV
    Biochim Biophys Acta; 1970 Sep; 215(3):517-21. PubMed ID: 4918821
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative properties of human erythrocyte sialoglycopeptides released by trypsin.
    Seaman GV; Jackson LJ
    Biochem Biophys Res Commun; 1971 Sep; 44(5):1050-5. PubMed ID: 5160397
    [No Abstract]   [Full Text] [Related]  

  • 15. CRYPTANTIGENIC N-VG RECEPTOR IN MUCOIDS FROM MU/MU CELLS.
    UHLENBRUCK G; KRUEPE M
    Vox Sang; 1965; 10():326-32. PubMed ID: 14332933
    [No Abstract]   [Full Text] [Related]  

  • 16. The red cell phenotype En(a-) and anti-Ena: serological and physicochemical aspects.
    Furuhjelm U; Myllylä G; Nevanlinna HR; Nordling S; Pirkola A; Gavin J; Gooch A; Sanger R; Tippett P
    Vox Sang; 1969 Oct; 17(4):256-78. PubMed ID: 4982653
    [No Abstract]   [Full Text] [Related]  

  • 17. New form of A-, B-, and H-blood-group-active substances extracted from erythrocyte membranes.
    Gardas A; Kościelak J
    Eur J Biochem; 1973 Jan; 32(1):178-87. PubMed ID: 4119911
    [No Abstract]   [Full Text] [Related]  

  • 18. Physicochemical properties of some glycopeptides released from human erythrocyte membranes by trypsin.
    Jackson LJ; Seaman GV
    Biochemistry; 1972 Jan; 11(1):44-9. PubMed ID: 5061870
    [No Abstract]   [Full Text] [Related]  

  • 19. On the specificity of lectins with a broad agglutination spectrum. X. Investigations on the soja hispida lectin.
    Dahr W; Uhlenbruck G
    Blut; 1971 Mar; 22(3):128-32. PubMed ID: 5102582
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of blood-group substances in interactions between man and microbes.
    Springer GF
    Ann N Y Acad Sci; 1970 Feb; 169(1):134-52. PubMed ID: 4908523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.